{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:13:22Z","timestamp":1794050002695,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013340","name":"Institute Pasteur De Lille","doi-asserted-by":"publisher","award":["U1177"],"award-info":[{"award-number":["U1177"]}],"id":[{"id":"10.13039\/501100013340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013340","name":"Institute Pasteur De Lille","doi-asserted-by":"publisher","award":["F-59000"],"award-info":[{"award-number":["F-59000"]}],"id":[{"id":"10.13039\/501100013340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["20-PAMR-0005"],"award-info":[{"award-number":["20-PAMR-0005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["ACIP 03\\u20132016"],"award-info":[{"award-number":["ACIP 03\\u20132016"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebiom.2025.105611","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:40:15Z","timestamp":1740487215000},"page":"105611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4384-3353","authenticated-orcid":false,"given":"Amandine","family":"Sury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Maex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Baulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roby P.","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Depick\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah T.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-6643","authenticated-orcid":false,"given":"Fadel","family":"Sayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Frigui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-3863","authenticated-orcid":false,"given":"Roland","family":"Brosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Mathys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"De Keersmaeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Rigouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter-Jan","family":"Ceyssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-0241","authenticated-orcid":false,"given":"An","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105611_bib1","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105611_bib2","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1128\/JCM.05434-11","article-title":"Evaluation of the GeneXpert MTB\/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens","volume":"49","author":"Zeka","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105611_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00632-20","article-title":"Application of targeted next-generation sequencing assay on a portable sequencing platform for culture-free detection of drug-resistant tuberculosis from clinical samples","volume":"58","author":"Cabibbe","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2178243","article-title":"Designing molecular diagnostics for current tuberculosis drug regimens","volume":"12","author":"Georghiou","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105611_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01677-19","article-title":"Validation of bedaquiline phenotypic drug susceptibility testing methods and breakpoints: a multilaboratory, multicountry study","volume":"58","author":"Kaniga","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48401-z","article-title":"Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance","volume":"9","author":"Torrea","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105611_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.990312","article-title":"Transcriptional regulation and drug resistance in Mycobacterium tuberculosis","volume":"12","author":"Miotto","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"38","key":"10.1016\/j.ebiom.2025.105611_bib9","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M406796200","article-title":"The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action","volume":"279","author":"Boshoff","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2025.105611_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tube.2019.05.002","article-title":"Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid","volume":"117","author":"Van den Bossche","year":"2019","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ebiom.2025.105611_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00249","article-title":"Genome-wide transcriptional responses of Mycobacterium to antibiotics","volume":"10","author":"Briffotaux","year":"2019","journal-title":"Front Microbiol"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105611_bib12","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1073\/pnas.96.22.12833","article-title":"Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization","volume":"96","author":"Wilson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105611_bib13","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41591-019-0650-9","article-title":"Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination","volume":"25","author":"Bhattacharyya","year":"2019","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105611_bib14","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1073\/pnas.1119540109","article-title":"RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities","volume":"109","author":"Barczak","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105611_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00202-21","article-title":"A\u00a0bioinformatics whole-genome sequencing workflow for clinical Mycobacterium tuberculosis complex isolate analysis, validated using a reference collection extensively characterized with conventional methods and in silico approaches","volume":"59","author":"Bogaerts","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ebiom.2025.105611_bib16","series-title":"Catalogue of Mutations in Mycobacterium tuberculosis Complex and their Association with Drug Resistance","year":"2023"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2025.105611_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tube.2003.12.005","article-title":"The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds","volume":"84","author":"Waddell","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-020-1172-4","article-title":"Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients","volume":"20","author":"Kabir","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105611_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105611_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12864-019-5782-2","article-title":"Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture","volume":"20","author":"Nimmo","year":"2019","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ebiom.2025.105611_bib21","series-title":"Technical Report on Critical Concentrations for Drug Susceptibility Testing of Isoniazid and the Rifamycins (Rifampicin, Rifabutin and Rifapentine)","year":"2021"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105611_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01599-17","article-title":"Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of Mycobacterium tuberculosis","volume":"56","author":"Miotto","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ebiom.2025.105611_bib23","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.2147\/IDR.S386863","article-title":"rpoB mutations are associated with variable levels of rifampin and rifabutin resistance in Mycobacterium tuberculosis","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105611_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00754-22","article-title":"Differential impact of the rpoB mutant on rifampin and rifabutin resistance signatures of Mycobacterium tuberculosis is revealed using a whole-genome sequencing assay","volume":"10","author":"Yu","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105611_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/AAC.01611-09","article-title":"Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor","volume":"54","author":"Huitric","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105611_bib26","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis","volume":"60","author":"Almeida","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105611_bib27","article-title":"Whole genome sequencing for the analysis of drug resistant strains of Mycobacterium tuberculosis: a systematic review for bedaquiline and delamanid","volume":"9","author":"Nieto Ramirez","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105611_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac029","article-title":"Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review","volume":"4","author":"Mallick","year":"2022","journal-title":"JAC Antimicrob Resist"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105611_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105611_bib30","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","article-title":"Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis","volume":"4","author":"Sonnenkalb","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2025.105611_bib31","series-title":"Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-resistant Tuberculosis","year":"2018"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105611_bib32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh","year":"2020","journal-title":"J\u00a0Appl Microbiol"},{"key":"10.1016\/j.ebiom.2025.105611_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis","volume":"45","author":"Unissa","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105611_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"643","key":"10.1016\/j.ebiom.2025.105611_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6280","article-title":"The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis","volume":"14","author":"Flipo","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138920013804545151","article-title":"Metabolism of the antituberculosis drug ethionamide","volume":"14","author":"Vale","year":"2013","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.ebiom.2025.105611_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.20151248","article-title":"Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in\u00a0vitro and in\u00a0vivo","volume":"213","author":"Liu","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105611_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090569","article-title":"Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results","volume":"9","author":"Ocheretina","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105611_bib39","doi-asserted-by":"crossref","first-page":"731.e9","DOI":"10.1016\/j.cmi.2021.09.014","article-title":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2025.105611_bib40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2147\/IDR.S358301","article-title":"Detection of Mycobacterium tuberculosis rifampicin resistance conferred by borderline rpoB mutations: Xpert MTB\/RIF is superior to phenotypic drug susceptibility testing","volume":"15","author":"Xia","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105611_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00783-2021","article-title":"Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown","volume":"58","author":"Van Deun","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ebiom.2025.105611_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diagmicrobio.2018.06.015","article-title":"The stability of antimycobacterial drugs in media used for drug susceptibility testing","volume":"92","author":"Schoutrop","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105611_bib43","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1128\/JCM.02489-13","article-title":"Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB\/RIF are associated with poor clinical outcomes","volume":"52","author":"Zetola","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105611_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Sci Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:01Z","timestamp":1762618561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"alternative-id":["S2352396425000556"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105611","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105611"}}